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Genomes are subject to constant threat by damaging agents that generate DNA double-strand
breaks (DSBs). The ends of linear chromosomes need to be protected from DNA damage recognition
and end-joining, and this is achieved through protein–DNA complexes known as telomeres. The
Mre11–Rad50–Nbs1 (MRN) complex plays important roles in detection and signaling of DSBs, as well
as the repair pathways of homologous recombination (HR) and non-homologous end-joining
(NHEJ). In addition, MRN associates with telomeres and contributes to their maintenance. Here,
we provide an overview of MRN functions at DSBs, and examine its roles in telomere maintenance
and dysfunction.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
DNA double-strand breaks (DSBs) can be generated by chemical
and physical damage inﬂicted by ionizing radiation, select chemo-
therapy drugs, and metabolic byproduct reactive oxygen species.
DSBs can also result from errors during replication, and are pro-
duced by programmed enzymatic activities during meiosis and
V(D)J recombination. Regardless of how they are generated, DSBs
differ from all other types of DNA lesions in that the sequence
information requisite for guiding repair is no longer contained
within a contiguous duplex molecule. If left unrepaired, DSBs are
among the most deleterious DNA lesions, with the potential to gen-
erate chromosomal translocations, aneuploidy, and increased inci-
dence of malignancy. The importance and centrality of DSB repair
pathways during the course of evolution is demonstrated by con-
servation of the core components from yeast to mammals. There
are two major competing pathways for DSB repair: homologous
recombination (HR) and non-homologous end-joining (NHEJ).
Although we do not fully understand the regulation of pathway
choice, the relative extent to which these two pathways are em-
ployed depends on the cell type, the phase of the cell cycle in
which the DNA damage is encountered, and also varies between
species [1,2].
At least three distinct functionalities are required for repair of
DSBs: detection of the damage, an ability to control the cell cyclechemical Societies. Published by E
an).and transcriptional programs in response to the damage, and
mechanisms for catalyzing repair of the lesion. The Mre11–
Rad50–Nbs1 (MRN) complex sits at the hub of the eukaryotic
DSB response mechanism, and has emerged as a crucial player in
each of these three facets of DSB repair. This complex of proteins
acts as DSB sensor, co-activator of DSB-induced cell cycle check-
point signaling, and as a DSB repair effector in both the HR and
NHEJ pathways [3–7]. The MRN complex has also been found to
associate with telomeres at the ends of linear chromosomes, where
it contributes to their maintenance. Since MRN promotes sensing
and repair of DNA ends, its presence at chromosome termini ap-
pears paradoxical. In this review, we ﬁrst provide an overview of
MRN’s constituents, structure, catalytic activities, protein-binding
partners, and signal transduction roles in the context of DSB repair
within non-telomeric regions of the chromosome. We then discuss
the emerging roles of the MRN complex in telomere maintenance
and dysfunction.
2. The MRN complex
Mre11, Rad50, and Xrs2 (the Saccharomyces cerevisiae homolog
of vertebrate-speciﬁc Nbs1) were ﬁrst identiﬁed via screens for
yeast genes involved in meiotic recombination, and resistance to
DNA damage induced by UV light and X-rays. Consistent with
the nearly identical phenotypes resulting from defects in these
three genes, Ogawa and co-workers demonstrated that Mre11,
Rad50, and Xrs2 belong to the same epistasis group [8], and subse-
quently these proteins were shown to associate physically withlsevier B.V. All rights reserved.
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speciﬁc features of each of the main components of the complex.
2.1. Mre11
Mre11 is a highly conserved 70–90 kDa protein composed of an
N-terminal Mn2+/Mg2+-dependent [12] phosphoesterase domain,Fig. 1. Characteristics of the MRN complex. (A) Domain organization of Mre11, Rad50,
complex. While there is evidence that multiple MRN complexes can cluster at DNA termi
of MRN complexes at DNA termini, and the subsequent tethering of multiple DNA molec
complexes are depicted by spheres.and two distinct C-terminal DNA-binding domains [13,14]
(Fig. 1A). Isolated Mre11 forms stable dimers [15] that possess a
number biochemical activities including: (i) intrinsic DNA binding
activity [9,16,17] with the speciﬁc ability to synapse DSB termini
[15], and (ii) endo- and exonuclease activities against a variety of
single-stranded DNA (ssDNA) and double-stranded DNA (dsDNA)
substrates [17,18]. While these nuclease activities contribute toand Nbs1. (B) Model of intermolecular interactions within the MRNDNA ternary
ni, for simplicity only a single complex is depicted. See text for details. (C) Clustering
ules via the coiled-coil arms of Rad50. The DNA-binding globular heads of the MRN
3684 B.J. Lamarche et al. / FEBS Letters 584 (2010) 3682–3695both NHEJ [19] and HR [20], it should be noted that Mre11 conspic-
uously lacks the 50?30 exonuclease activity requisite for generating
the long 30 ssDNA overhangs necessary for HR. Although it is pos-
sible that a protein-binding partner might switch the polarity of
the exonuclease activity of Mre11, it is more likely that Mre11
facilitates the activity of additional DSB processing factors. In both
yeast and mammals a number of 50?30 exonucleases have been
identiﬁed [12,21] that are capable of contributing to the generation
of 30 overhangs during HR, giving weight to the idea that other en-
zymes act in concert with MRN [22].
In vivo, Mre11 exists in Mre112Rad502 ‘‘core” complexes where
each Mre11 molecule binds a single Rad50 (Fig. 1B). The Nbs1 or
Xrs2 proteins bind this core complex via interactions with Mre11
to give an overall stoichiometry of Mre112Rad502Nbs12, although
there is some discrepancy over the number of Nbs1 proteins bound
to the MR complex [11,23]. Supporting the importance of these
interactions to MRN complex stability and function, Mre11 muta-
tions that destabilize the MRN complex result in signiﬁcantly de-
creased levels of Rad50 and Nbs1 in vivo [17,24], and knockdown
of individual components of MRN can produce decreases in the
other two members [25]. In reconstitution studies the addition of
Rad50 enhances the afﬁnity of Mre11 for DNA and stimulates its
nuclease activity, and this is further enhanced by the addition of
Nbs1 [17].
2.2. Rad50
Rad50 is a 150 kDa protein displaying both sequence and
structural homology to structural maintenance of chromosome
(SMC) family members that control the higher-order structure
and dynamics of chromatin. The N-terminal Walker A and C-termi-
nal Walker B nucleotide binding motifs stably associate with one
another to form a bipartite ATP-binding cassette (ABC)-type ATP-
ase domain [26,27] that preferentially binds and partially unwinds
dsDNA termini [28]. The intervening 575 amino acids form an
anti-parallel coiled-coil that spans 500 angstroms and terminates
with a zinc hook (CxxC) motif [29] (Fig. 1A and B). Formation of the
stable Mre112Rad502 core complex is achieved by each unit of the
Mre11 dimer binding a Rad50 molecule at the intersection of its
globular and coiled-coil domains [27,28]. This results in a spatial
juxtaposition of the DNA-binding/termini-unwinding capacities
of Rad50 with the DNA-binding, DSB tethering, and nuclease activ-
ities of Mre11 (Fig. 1B).
Independent of the Mre11-mediated dimerization of Rad50,
biochemical analyses indicate that isolated Rad50 is able to form
robust dimers under certain conditions [30]. Consistent with this,
a crystal structure demonstrated that the globular ATPase/DNA-
binding domains from two Rad50 molecules can associate [26].
Importantly, this interaction is ATP-dependent, with two ATP mol-
ecules getting sandwiched within the Rad50–Rad50 interface
(Fig. 1B). Hopfner and co-workers deemed ATP hydrolysis by this
complex too inefﬁcient to support motor or helicase functions,
and therefore proposed a ‘‘switch” function instead [26]. This
‘‘switch hypothesis” predicts that within the context of the
Mre112Rad502Nbs12 complex, the two Rad50 molecules toggle be-
tween states in which their ATPase/DNA-binding domains are
associated or disassociated (Fig. 1B). Since ATP binding-induced
structural changes dramatically enhance the afﬁnity of Rad50 for
linear double-stranded DNA [26], an ATP binding/hydrolysis cycle
may be a mechanism for modulating the length of time the MRN
complex remains bound to a substrate or product.
Scanning force microscopy has demonstrated that while the
globular head of the Mre112Rad502 complex associates with the
termini of linear dsDNA, the two coiled-coil regions of Rad50 are
ﬂexible ‘‘arms”, and project outward away from the DNA [28]
(Fig. 1B). With increasing concentration, Mre112Rad502 complexesoligomerize at dsDNA termini, where the coiled-coil arms of
Mre112Rad502 complexes mediate interactions between DNA ter-
mini [28] (Fig. 1C). Since this tethering of DNA termini was not ob-
served at lower protein concentrations where only a single
Mre112Rad502 complex was associated with a given DNA termi-
nus, it was suggested that this may be a mechanism for achieving
a robust and speciﬁc DSB tethering effect through the use of multi-
ple weak interactions [28]. Crystallographic studies subsequently
demonstrated that it is the zinc hook of Rad50 that mediates inter-
action between the coiled-coil arms of Rad50 molecules [29]
(Fig. 1B). Mutation of the zinc-coordinating cysteine residues of
Rad50 resulted in signiﬁcant DSB repair defects in yeast, and com-
plete replacement of the zinc hook with an FKBP dimerization cas-
sette mitigated this repair defect [31]. This suggests that the ability
of Rad50 molecules to bind one another via the distal terminus of
their coiled-coil arms is important for MRN function.
The available structural and functional data indicate that a ma-
jor role of the MRN complex is to mediate spatial juxtaposition of
DNA molecules, and that this involves two distinct modes of bind-
ing. In the current model, the Mre11 dimer facilitates short-range
synapsis of the two ends of a DSB, while Rad50 enables long-range
tethering of two DNA molecules (such as a broken chromosome
and its sister chromatid) by dimerizing via its zinc hook (Fig. 1B)
[15,29]. In its fully extended conformation, the zinc-mediated
Rad50 dimer places the two DNA molecules being bound by each
Rad50/Mre11 globular head 1200 angstroms from each other
[29]. Importantly, however, the coiled-coils of Rad50 are extremely
ﬂexible, suggesting that even while they remain tethered by Rad50
the sister chromatids would be capable of achieving a tighter spa-
tial proximity more conducive to homology-mediated repair.
2.3. Nbs1
The third member of the MRN complex is Nbs1, a 65–85 kDa
protein. Nbs1 consists of an FHA domain and two adjacent BRCT
domains at its N-terminus, in addition to an Mre11-interaction do-
main at its C-terminus [32,33] (Fig. 1A and B). The FHA domain
binds phosphorylated threonine residues in Ser-X-Thr motifs pres-
ent in DNA damage proteins, including Mdc1 and Ctp1. The BRCT
domains in human Nbs1 bind Ser-X-Thr motifs when the serine
residue is phosphorylated. These phospho-dependent interactions
are important for recruiting repair and checkpoint proteins to
DNA breaks [32,33]. By virtue of its nuclear localization signal
and its interaction with Mre11, Nbs1 is responsible for transloca-
tion of the MRN complex into the nucleus. This can be observed
with Nbs1 mutants lacking the Mre11-binding domain, which
are themselves nuclear, while the Mre112Rad502 core complex re-
mains cytoplasmic [34].
Limited proteolysis of Nbs1 yields a stable N-terminal fragment
and C-terminal degradation products, suggesting that the FHA/
BRCT core of Nbs1 is linked to Mre11 via a ﬂexible tether [33]
(Fig. 1B). While Nbs1 stimulates the DNA binding and nuclease
activities of the MR complex [17], it does not itself possess a known
enzymatic activity. Rather, Nbs1 contributes to DSB repair primar-
ily by mediating protein–protein interactions at DNA breakage
sites. The central region of Nbs1 possesses several SQ motifs that
are phosphorylated by the ATM kinase as part of the DNA damage
response. The C-terminus also contains a domain that interacts
with ATM and recruits it to DSBs [35,36], and is required for the
induction of apoptosis in response to damage [37].
3. MRN mutations: human diseases and mouse models
In humans, hypomorphic mutations in the NBS1 gene result in
Nijmegen breakage syndrome (NBS) [38,39], a rare autosomal
recessive disorder characterized by microcephaly, immunodeﬁ-
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mutation in NBS patients is 657del5, which results in truncated
proteins that partially maintain some functions of the full length
protein: a short N-terminal fragment that includes the FHA/BRCT
domains can be detected, and in some cell types there is also a
70 kD C-terminal fragment which is capable of interacting with
Mre11. Hypomorphic mutations in human MRE11 lead to atax-
ia-telangiectasia-like disorder (A-TLD) [24], in which patients
display ataxia and neurodegeneration, resembling the pheno-
types of ATM deﬁciency [41]. A single patient has been reported
with a hypomorphic mutation in RAD50, who exhibited pheno-
types similar to NBS [42]. Patients with NBS are prone to devel-
oping malignancies such as lymphoma and leukemia [40], and
somatic alterations in MRN may contribute more widely to car-
cinogeneisis [43]. Cell lines derived from NBS and A-TLD patients
have been valuable in dissecting the functions of MRN and the
consequences of compromised function. Consistent with the
involvement of MRN in cell cycle checkpoint signaling and
DNA repair, cells from patients with NBS and A-TLD display in-
creased radio-sensitivity and are defective for checkpoint activa-
tion [24,38].
Animal models of MRN defects have been useful in understand-
ing the pathology of human disease. Null mutations in members of
the MRN complex lead to embryonic lethality in mice, and there-
fore mouse models have been generated to mimic the hypomor-
phic mutations identiﬁed in human. Models have been made for
A-TLD (Mre11ATLD1/ATLD1) [44] and NBS (by generating truncated
proteins NBSDb/Db and NBSm/m, as well as a humanized NBS syn-
drome mouse model hNBS657D5) [45,46]. In addition, insights have
been gleaned from mice engineered to express either Nbs1 mu-
tants lacking speciﬁc domains [37,47] or the Rad50S hypermorphic
mutation initially described in S. cerevisiae (Rad50S/S) [48]. While
the disease phenotypes of these mouse models are less severe than
those in the corresponding human disorders, together with cell and
tissue speciﬁc knockouts, they can individually recapitulate vari-
ous aspects of the human disease including immunodeﬁciency,
cancer predisposition, and germline and neuronal defects
[46,49,50].
Immunological deﬁciency, including defects in both humoral
and cellular immunity, is a hallmark of human NBS. Speciﬁcally,
human B-cells display decreased variability in IgG and IgA sub-
types (compared to the IgM subtype), and an increased susceptibil-
ity to lymphogenesis. Conditional mouse models with targeted
deletion of NBS in B lymphocytes revealed that the decreased
immunoglobulin variability is due to a defect in class switch
recombination (CSR) [51]. Since CSR requires repair of the DSBs in-
duced as intermediates in the process, the basis for CSR defects in
MRN deﬁcient cells is likely due to the functions of MRN in NHEJ,
although signaling defects could also contribute.
Cancer predisposition and chromosomal instability in NBS pa-
tients appears in the form of lymphomas, particularly B-cell lym-
phomas. NBS, A-TLD, and Rad50S/S mice display increased
tumorigenesis in a p53 null background, while Nbs1 heterozygotes
are susceptible to various types of cancers independent of p53
[46,52]. Cells derived from the model animals are sensitive to ion-
izing radiation, defective for checkpoint activation and display in-
creased amounts of chromosomal aberrations [45,48,52,53].
Germ line defects in NBS patients include infertility and com-
promised sexual maturation. The hNBS657D5 mouse recapitulates
these effects when compared to littermate controls [46]. The male
mice have smaller testes with histological degeneration, increased
apoptosis, and delayed appearance of germ cells. The adult female
mice fail to breed and have small ovaries devoid of oocytes. Anal-
ysis of meiotic chromosome spreads in oocytes at birth reveals
depletion in the diplotene stage, suggesting that Nbs1 is required
for meiotic progression. Analysis of meiotic events in mice harbor-ing the hypomorphic Mre11 and Nbs1 mutations also revealed de-
fects in synapsis of homologous chromosomes and crossovers, and
suggested that MRN contributes to normal sex-speciﬁc differences
in meiosis [54].
Neurological defects are a hallmark of MRN mutation, with
microcephaly and ataxia observed in NBS patients, and neurode-
generation detected in A-TLD patients [55]. These different neurop-
athies are probably reﬂective of the fact that the respective
disease-causing mutations differentially impact DNA damage sig-
naling in the brain. Conditional disruption of the murine ortholog
of the human NBS1 gene in the mouse central nervous system
(CNS) causes ataxia, microcephally, cerebellar disorganization
and disruption of the visual system [50,56]. Although the hypo-
morphic NBS and A-TLD mice did not exhibit neurological defects,
when damage was introduced during development these mice dis-
played distinct neurological phenotypes which were attributed to
differential activation of an apoptotic response [44,52,57]. The
MRN complex is required for activation of the ATM-dependent
p53 apoptotic response either during neural development, or un-
der conditions of DNA damage [56,57]. NBS mice expressing the
C-terminal domain of Nbs1 retain the ability of Nbs1 to interact
with Mre11 and ATM, and this is sufﬁcient to activate an ATM-
dependent DNA damage response [35–37], which can lead to apop-
tosis during neuronal development and result in microcephaly
[57]. In contrast, A-TLD mice subjected to ionizing radiation do
not exhibit normal ATM signaling, p53 activation, and apoptosis.
Therefore, accumulation of mutations and genomic damage in
these cells may be responsible for the neurodegeneration seen in
A-TLD patients [57].
4. The multiple roles of MRN in DSB repair
The MRN complex plays critical roles in pathways involved in
DNA damage repair, checkpoint activation, telomere maintenance,
meiosis and DNA replication. As a prelude to our discussion of MRN
functions in telomere maintenance, here we focus on the activities
of the complex most relevant to detection and repair of DSBs. We
refer the reader to excellent recent articles that review additional
aspects of MRN function in meiosis, replication and checkpoint sig-
naling [13,58–60].
4.1. MRN-mediated DSB detection and activation of signal
transduction
Coordination of the DNA damage surveillance and repair sys-
tems functions to prevent transmission of genetic mutations [61].
Sensors detect damaged DNA and activate protein kinases that
launch a network of signal transduction cascades that form the
DNA damage response (DDR) [62]. This network prevents an array
of human diseases, and when compromised it can lead to genomic
instability and cancer [61]. The primary signaling kinases are the
ataxia telangiectasia mutated protein (ATM), the ATM and Rad3-
related kinase (ATR), and the DNA-dependent protein kinase
(DNA-PK). When these DNA damage kinases are activated they
phosphorylate a speciﬁc serine residue of histone H2AX at the
breakage site and ﬂanking chromatin [63,64]. Proteins involved
in repair and checkpoint activation subsequently accumulate at
the DSB to form foci that are visible by ﬂuorescent microscopy.
Post-translational modiﬁcations to histones and repair proteins
determines the temporal order of accumulation at the sites of dam-
age [65,66]. Recruited proteins are involved in signal ampliﬁcation,
chromatin modiﬁcation, and repair of the DSB. The kinase path-
ways induced by DSBs in human cells result in phosphorylation
of more than 700 different proteins, including the mediators
Mdc1 and 53BP1, downstream checkpoint kinases Chk1 and
Chk2, and proteins with a diverse array of functions [67]. Signaling
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cycle progression: the G1/S checkpoint prevents cells from enter-
ing S phase, the intra-S checkpoint inhibits replication during S
phase, and the G2/M checkpoint prevents damaged cells from
entering mitosis. Checkpoint activation can be accompanied by
changes in cellular transcription proﬁles and apoptotic death
pathways.
The MRN complex plays a role very early in the DDR, acting as a
sensor of DSBs [68]. It has been demonstrated that mutation,
knockdown, degradation, or mislocalization of MRN components
leads to defective ATM signaling [24,69–71]. In addition to being
present diffusely throughout the nucleus [72], a fraction of the
MRN complex is also sequestered within sub-nuclear compart-
ments known as promyelocytic leukemia (PML) bodies [73]. Con-
sistent with the role of MRN as a DSB sensor, the concentration
of MRN components remains constant throughout the cell cycle
[72]. Immunoﬂuorescence (IF) analyses indicate that upon DSB for-
mation, the MRN complex rapidly relocalizes from both the diffuse
pool and PML bodies to breakage sites [73,74]. MRN can be de-
tected within these repair foci using standard IF because hundreds,
if not thousands, of copies of the protein complex accumulate
within the vicinity of the DSB [75]. Rapid recruitment of ﬂuores-
cently labeled Nbs1 has also been demonstrated in live human
cells with DSBs generated by laser micro-irradiation, which is re-
stricted to small sub-nuclear areas [76]. Potential beneﬁts of such
rapid detection are that it minimizes (i) the time that free DNA ter-
mini remain vulnerable to non-speciﬁc degradation, and (ii) the
amount of time that DSB termini are able to diffuse away from
one another. In the presence of multiple DSBs, the latter would
serve to maximize the probability of MRN synapsing the two
termini that were originally contiguous.
In undamaged cells, ATM exists as a homodimer that is incapa-
ble of phosphorylating its substrates [77], presumably because
dimerization occludes substrate binding. Upon induction of DSBs
by ionizing radiation ATM is recruited to DSBs, at least in part,
via a direct interaction with a C-terminal motif in Nbs1 [35,36]
(Fig 1A). This evolutionarily conserved C-terminal region of Nbs1
may not be absolutely required for recruitment and activation of
ATM [37,47], since its loss appears to be compensated for by medi-
ators such as 53BP1 [78]. By monitoring laser micro-irradiation-in-
duced DSBs in real time, it was demonstrated that an MRN-
dependent accumulation of ATM occurs within seconds [79]. This
MRN–ATM interaction, which is optimal in the presence of dsDNA
termini [35,80] and is stimulated by Rad50-mediated melting of
the duplex terminus [80], increases the effective concentration of
ATM in the vicinity of the DSB and also promotes the autophospho-
rylation of ATM dimers [80]. Autophosphorylation of ATM at serine
1981 triggers dissociation of the inactive dimer into kinase active
monomers [77]. Autophosphorylation of ATM is essential to the
DSB response not only because of the subsequent dissociation to
active monomers, but also because it enables ATM to be retained
at the breakage site [81]. The S1981A mutant of human ATM,
which forms dimers that cannot be activated via autophosphoryla-
tion, is initially recruited to DSBs at a rate similar to that of wild-
type ATM but is released from the break [79], and is consequently
incapable of catalyzing essential downstream phosphorylation
events [82].
At low doses of radiation the presence of functional MRN com-
plex enhances activation of ATM, although there are also MRN-
independent mechanisms of ATM activation. Treatment of cells
with mild hypotonic solution or with the topoisomerase II inhibitor
chloroquine, both of which induce chromatin structural changes
without inducing DSBs, triggers ATM activation to a degree similar
to that achieved by ionizing radiation [77]. Moreover, it was re-
cently shown that modiﬁcation of chromatin structure by inhibi-
tion of histone deacetylases can also activate ATM [83,84].Activation of ATM via these types of chromatin modiﬁcation (in
the absence of DSBs) results in ATM-mediated phosphorylation
of p53 [77] but not of proteins such as Nbs1 or SMC1 that are inte-
gral to the DSB coping mechanism [82]. This raises the possibility
that upon DSB formation, ATM is actually responding to a change
in the higher order structure of chromatin. In addition to MRN,
other proteins recruited through ATM interactions, such as Tip60
[85], may contribute to ATM activation and modiﬁcation of chro-
matin at DSBs. Stimuli that alter chromatin and induce ATM activa-
tion in the absence of DSBs may also involve additional ATM-
binding proteins, such as ATMIN, that could compete with Nbs1
[86].
In addition to recruitment of ATM and activation of it’s signal-
ing, MRN also participates in the early steps of end resection at
DSBs (see below) and this leads to subsequent activation of the
ATR kinase [87]. Processing of DSBs is required to generate the sub-
strates that lead to ATM-dependent activation of the ATR kinase
[88]. It is proposed that ATM activation leads to resection of the
DNA ends at breaks [87], and that production of single-stranded
tails transforms the ends from ATM substrates into ATR substrates
[88]. In support of this model, the nuclease activity of Mre11 has
been shown to contribute to ATR activation in a mouse model
[89]. In response to other types of DNA damage, functional MRN
complex also promotes ATM-independent activation of the ATR
kinase, although the mechanism by which this occurs is not clear
[25,90–93]. It has also been shown in Xenopus Laevis extracts that
MRN-dependent processing of DSBs leads to the accumulation of
short single-stranded DNA oligonucleotides that stimulate ATM
activity [94], and these could have relevance for ATR signaling.
Activation of ATM and ATR at DSBs initiates a signaling network
that (i) provides regulation of the cell cycle (via the protein kinases
Chk1 and Chk2) [95], (ii) promotes chromatin remodeling that is
necessary for allowing the repair machinery access to the lesion
[81,96], and (iii) contributes to the recruitment and retention of
additional proteins responsible for repairing the break. The DSB-in-
duced signaling cascade that mediates checkpoint activation and
lesion repair involves a large number of proteins and post-transla-
tional modiﬁcations (phosphorylation, acetylation, methylation,
ubiquitinylation, sumoylation) that have been recently reported
and reviewed elsewhere [66,85,95,97–100].
4.2. Repair pathway selection: HR versus NHEJ
The relative extent to which DSBs are repaired via HR versus
NHEJ varies among different species and cell types. In yeast and
the simpler eukaryotes, which possess compact genomes and a rel-
ative paucity of repetitive sequences, HR makes a greater contribu-
tion to DSB repair. However, in mammals, where intergenic regions
are larger and repetitive regions more abundant, it has been sug-
gested that NHEJ is faster and more efﬁcient [101]. This predispo-
sition towards NHEJ in mammals may reﬂect the fact that gross
chromosomal rearrangements can arise if the wrong region is uti-
lized during HR, in a templating molecule containing multiple re-
gions of repetitive sequence [102]. Although a given organism
may display a general preference for HR or NHEJ, the extent to
which each pathway is employed temporally ﬂuctuates depending
on the phase of the cell cycle [103].
There are multiple HR sub-pathways [104], but the deﬁning fea-
ture of HR in mitotic cells is that it utilizes the sister chromatid to
guide repair of a DSB during the S and G2 phases of the cell cycle
[2]. In meiotic cells, HR utilizes either the homologous chromo-
some or the sister chromatid to guide repair during the ﬁrst and
second meiotic divisions, respectively [105]. During HR, exonucle-
olytic processing generates long 30 ssDNA overhangs on each side
of the DSB which invade and base pair with the homologous re-
gions of the intact sister chromatid (or homologous chromosome),
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plex yields two intact chromosomes of identical sequence, ensur-
ing high ﬁdelity during the HR repair process.
In contrast to HR, NHEJ is suppressed during meiosis and is
mainly employed during the G0, G1, and early S-phases of the mi-
totic cell cycle, when sister chromatids are not present to guide re-
pair [1]. During NHEJ the ends of the break are joined irrespective
of their sequence, and this pathway is therefore inherently error-
prone. In NHEJ repair the two termini of the DSB are either directly
ligated in classical NHEJ (C-NHEJ), or distal regions of microhomol-
ogy (consisting of 1–4 nucleotides) on each side of the DSB are uti-
lized to align the fragments prior to ligation during the alternative
NHEJ (A-NHEJ) pathway (Fig. 2A and B). In both types of NHEJ, pro-
cessing of the termini via nuclease-mediated removal of nucleo-
tides or polymerase-mediated gap ﬁlling may be employed. This
ability to repair DSBs whose termini display little or no homology
is both the strength and the weakness of NHEJ, in that a lethal DSB
is traded for a small deletion or insertion. In the presence of multi-
ple DSBs, NHEJ repair can give rise to gross chromosome rearrange-
ments, such as inversions and translocations [106], because there
is no mechanism for determining which of the multiple DNA ter-
mini were originally contiguous.
Resection at DSBs plays a central role in determining the out-
come of the competition between HR and NHEJ. During the S andFig. 2. Models of NHEJ. (A) C-NHEJ, also known as direct end joining, is carried out with
termini are amenable to C-NHEJ. A single DSB can be processed via multiple routes, with
and polymerase activities are employed. Blue regions denote gaps ﬁlled in by a DNA poly
regions of microhomology are encountered which can guide reattachment of the DNA eG2 phases of the cell cycle, DSBs are resected to give extensive 30
ssDNA overhangs on each side of the break [87,107,108]. This
serves to generate a substrate for the HR-speciﬁc ssDNA-binding
factors RPA and Rad51, and thus ensures that the DSB will be re-
paired via HR [106]. It also reduces the efﬁciency of NHEJ because
the NHEJ-speciﬁc DNA termini binding factor Ku70/80 has poor
afﬁnity for ssDNA [109]. In contrast, during the G0 and G1 phases,
when sister chromatids are not present to facilitate HR, the cellular
DSB resection activity is downregulated [110], which gives the
NHEJ machinery opportunity to bind and process the break.
4.3. The contribution of MRN to repair pathway selection
The MRN complex, via its DNA end-processing activities, plays a
pivotal function in initiating the processes that direct a DSB down
the most appropriate repair pathway [22,106]. Although the MRN
complex plays a key role, it is not sufﬁcient and requires collabora-
tion with other factors. The exonuclease activity of Mre11 in vitro
operates in the opposite polarity to that required for HR resection
in vivo. This has prompted several groups to search for additional
factors that work with MRN to facilitate DSB processing. In bud-
ding yeast S. cerevisiae the Sae2 protein is required in conjunction
with MRX for processing meiotic DSBs and promoting resection
[111]. Sae2 has been suggested to be an endonuclease thatminimal processing of the DSB termini prior to ligation. Both blunt and protruding
the product sequence being determined by the chronology in which ligase, nuclease,
merase. (B) A-NHEJ involves modest resection of DSB ends (<100 nucleotides) until
nds. Regions of microhomology are depicted in green.
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process covalent protein-linked DSBs [113]. Ctp1 in the ﬁssion
yeast Schizosaccharomyces pombe [114] and CtIP in human cells
[115,116] have been proposed to be functional counterparts of
Sae2 for resection and repair pathway choice. Human CtIP under-
goes DSB-induced phosphorylation, localizes to DSB repair foci, di-
rectly binds the MRN complex, and catalyzes or confers upon MRN
the ability to catalyze 50?30 resection at DSBs [117]. By binding to
DSBs after ATM activation, CtIP appears to facilitate the transition
from DSB sensing to end-processing [118]. CtIP depletion results in
attenuated recruitment of RPA and ATR to damage induced by laser
micro-irradiation [116]. Since RPA binds the extensive 30 single-
stranded overhangs generated by DSB resection, and ATR is the
protein kinase that signals the presence of ssDNA, these data were
used to suggest that CtIP is integral to the DSB resection process
[116]. This is consistent with the reduction in HR frequency ob-
served with CtIP depletion. Simultaneous depletion of both CtIP
and Mre11 reduces HR frequency to the same degree as CtIP deple-
tion alone [116], suggesting that these proteins function within the
same pathway. In further support of this, deletion of the C-terminal
region of CtIP that mediates its interaction with MRN abrogates the
ability of CtIP to promote ssDNA formation [116]. Important ques-
tions remain relating to the speciﬁc role played by MRN/CtIP dur-
ing the DSB resection step of HR in mammalian cells. Human CtIP
shares only a very small stretch of homology with Sae2 and it has
not yet been demonstrated whether CtIP has nuclease activity.
After initial processing by a complex containing MRN and CtIP,
further resection by the combined action of other helicases and
nucleases generates the large regions of ssDNA required to com-
plete the HR pathway [22,106]. In S. cerevisiae, MRX/Sae2 catalyzes
the initial removal of a few hundred nucleotides from a DSB
[119,120] and subsequently the processive 50?30 ExoI exonuclease
or the Dna2 exonuclease (in conjunction with the Sgs1 helicase)
continue resection to give kilobase-sized 30 ssDNA overhangs
[119,120]. DSB resection in vertebrates likely proceeds via a similar
mechanism where resection is initiated by MRN/CtIP and then
completed by ExoI in conjunction with the BLM helicase [121].
Upon DSB induction, speciﬁc damage signals propagate outwards
from the break along chromatin, raising the possibility that it is
these modiﬁcations (and the resultant alteration of chromatin
structure) that restrict the MRX/Sae2- and ExoI-mediated phases
of resection to 100 nucleotides and 2–3 kb, respectively.
The mechanisms responsible for the cell cycle dependence of
the DSB resection activity are starting to come into focus. The abil-
ity to direct DSBs towards HR during S/G2 but not during G1 ap-
pears to be rooted in both the cellular concentration of CtIP and
its phosphorylation state [117]. Consistent with CtIP’s role in the
DSB resection step of HR, and the minimally detectable DSB resec-
tion activity seen in G1 extracts, CtIP is barely detectable during
G0/G1 but displays maximal concentration during S/G2 [122]. A
similar situation is seen for the S. pombe Ctp1 protein [114]. In
chicken cells, phosphorylation of CtIP speciﬁcally in S/G2 is essen-
tial for its function in the DSB resection step of HR [123]. It has
recently been shown in S. pombe that recruitment of Ctp1 by the
N-terminus of Nbs1 involves phosphorylation [33] and CK2 has
been suggested to mediate this phospho-dependent interaction
[124]. Phosphorylation may also play a role in recruitment of CtIP
in humans [115] and Sae2 in budding yeast [125], and in both cases
phosphorylation mediated by CDK provides an explanation for the
cell cycle control of DSB resection.
The extensive repertoire of structural and catalytic functions
attributed to MRN is utilized differently within the HR and NHEJ
pathways. The initial contribution of MRN to HR is that of DSB
sensing. In contrast, a unique set of NHEJ proteins are employed
for detecting, synapsing, and processing DSBs. Similar to MRN,
these NHEJ repair factors are present and active throughout the cellcycle [126]. It is presently unclear how MRN out-competes the
NHEJ machinery for its place at DSB termini during the S and G2
phases of the cell cycle. A signiﬁcant body of data indicates that
Ku suppresses HR [127–129] and reduces DSB resection during
HR [130], while loss or mutation of Ku increases the frequency at
which DSBs are processed via the HR pathway [131]. These data
support a model in which Ku and MRN, simultaneously present
throughout the cell cycle, compete for DSB termini. This raises
the issue of whether the initial DSB binding event is completely
random or alternatively whether there are mechanisms that pro-
mote Ku binding during G1 and MRN binding during S/G2. If
MRN binds a DSB during G1, 50?30 resection is prevented by both
the phosphorylation state and low concentration of MRN-associ-
ated CtIP. Whether an analogous mechanism for suppressing NHEJ
if Ku binds a DSB during S/G2 remains to be determined. If Ku or
MRN binds a DSB during an ‘‘inappropriate” phase of the cell cycle,
having a mechanism in place for actively removing themwould ap-
pear to be important. Indeed, it was recently shown that removal
of Ku from an unrepaired DSB is dependent on functional MRN,
and requires the ATP-binding function of Rad50 [132].
4.4. Repair functions of MRN in HR and NHEJ
The crystal structure of the Mre11 dimer bound to two DNA ter-
mini suggests that a single MRN complex spatially juxtaposes the
ends of a broken chromosome [15] (depicted in Fig. 1B). While this
short-range tethering (i.e., synapsis) function could conceivably be
useful in NHEJ, where termini undergo minimal processing prior to
ligation, it is not obvious that this would be beneﬁcial to HR where
DNA ends are resected to give expansive tracks of ssDNA. It is un-
clear whether DSB termini must be synapsed in order to initiate HR
50?30 resection or whether the termini can be bound and resected
independently of one another.
Although Mre11 endows the MRN complex with both ssDNA
endonuclease and dsDNA 30?50 exonuclease capabilities, these
nuclease activities do not have equal importance during HR. Wil-
liams and co-workers identiﬁed point mutations that abrogate
either the exonuclease activity or both the exo- and endonuclease
activities of Mre11 [15]. Studying these mutants in S. pombe indi-
cates that while 30?50 exonuclease activity is dispensable for HR,
loss of endonuclease activity results in a severe HR defect
approaching that observed for Mre11 knockout [15]. IR is capable
of producing DSBs in which the 30 moiety does not contain the
30-hydroxyl necessary for polymerase-mediated extension after
strand invasion/base pairing. Therefore, the 30?50 exo activity of
Mre11 would appear to be ideal for removing these 30 ‘‘blocking
groups”. The dispensability of the 30?50 exonuclease activity of
Mre11 in this experiment suggests that either (i) the assay is not
sensitive enough to detect defects in processing these 30 blocking
groups, which may be present in only a fraction of IR induced DSBs,
(ii) that the endonuclease activity of Mre11 can be utilized for
cleaning up 30 termini, or (iii) that a different nuclease is employed
in these situations. Evidence from a nuclease deﬁcient Mre11
mouse model (Mre11H129N/D) suggests a role for the nuclease activ-
ity in early events at DSBs during HR in higher eukaryotes [89].
Initial analyses of the importance of MRN to NHEJ produced
conﬂicting results [133,134], but emerging data have now ﬁrmly
established roles for MRN in both C- and A-NHEJ. In C-NHEJ, broken
termini are initially bound by the ring-shaped Ku70/Ku86 hetero-
dimer. These Ku-bound termini recruit and activate the DNA-
dependent protein kinase catalytic subunit (DNA-PKcs), which
phosphorylates repair factors and checkpoint proteins in a manner
analogous to, but distinct from, that of ATM during HR [135,136].
While Ku and DNA-PKcs mediate synapsis of the two DNA termini,
the Artemis nuclease cleans up the termini via both endo- and exo-
nuclease activities [137,138]. Finally, the XRCC4-DNA ligase IV
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sealing of both strands. C-NHEJ, also known as direct end-joining,
is carried out with minimal processing of the DSB termini prior
to ligation (Fig. 2A). In the absence of C-NHEJ factors such as
XRCC4, Ku, and DNA-PKcs, the recently described alternative A-
NHEJ pathway becomes more prevalent. A-NHEJ involves modest
resection of DSB ends (<100 nucleotides) until regions of microho-
mology are encountered which can guide reattachment of the DNA
ends (Fig. 2B). Multiple groups have demonstrated that deletion of
the XRCC4 gene both decreases the efﬁciency of NHEJ and causes a
shift from usage of C-NHEJ to utilization of A-NHEJ instead [5,7].
Sequencing the joints of repaired molecules can determine which
pathway has been employed. Recent studies show that siRNA-
mediated knockdown of Mre11 results in reduced end-joining efﬁ-
ciency in both XRCC4+/+ and XRCC4/ backgrounds [4,5]. This indi-
cates that MRN functions in both the C-NHEJ and A-NHEJ
pathways. The function of MRN in NHEJ appears to be independent
of ATM signaling since these results can be reproduced in the pres-
ence of a chemical inhibitor of ATM [5].
Although C-NHEJ is used predominantly in an XRCC4+/+ back-
ground, imprecise (i.e., deletion-prone) microhomology-mediated
A-NHEJ products are also detected. Depletion of Mre11 in a mouse
ES XRCC4+/+ background reduces the frequency at which DSBs are
repaired using microhomology, suggesting that Mre11 facilitates
resection in the search for microhomologies distal to the break
[5]. Nuclease-dead mutants can be used to determine whether
the role of Mre11 in this C-NHEJ-competent background is due to
tethering versus resection activities. In C-NHEJ-competent S. cere-
visiae, end-joining defects associated with Mre11 deletion can be
rescued by nuclease-defective Mre11, indicating a structural rather
than catalytic function for yeast Mre11 in this context [139]. When
the C-NHEJ system is compromised, as in the mouse ES XRCC4/
background, knockdown of Mre11 results in a decrease in the
length of resection tracks prior to end-joining [5]. Whether
Mre11 is itself catalyzing resection in the search for microhomolo-
gy or is simply facilitating this process has not been determined.
Depletion of CtIP in asynchronous SV40 transformed human ﬁbro-
blasts causes a signiﬁcant decrease in end-joining efﬁciency [4],
consistent with a facilitative role for MRN. These recent studies
indicate that in contrast to the situation with HR, knowledge of
the roles of MRN in NHEJ is just beginning to take shape. Among
the important questions that will need to be addressed are how
MRN facilitates repair, why it is not sterically occluded by the pres-
ence of the NHEJ machinery, and what the speciﬁc roles of Mre11
(and other nucleases) are in resection prior to end-joining.
5. MRN in telomere maintenance and dysfunction
The evolutionary transition from circular to linear chromo-
somes brought with it two new challenges to genome stability.
The ﬁrst of these, known as the ‘‘end replication problem”, relates
to the loss of nucleotides from the 50 terminus of the lagging strand
after every round of DNA replication. The second challenge to gen-
ome stability associated with linear chromosomes is that of pre-
venting the chromosome termini from being recognized and
processed as DSBs. The specialized repetitive sequences and pro-
tein–DNA complexes that comprise telomeres function both to
maintain the chromosome ends and to provide protection from
the DNA repair machinery.
Removal of the RNA primers from lagging strand Okazaki frag-
ments results in a gap of missing nucleotides at the 50 terminus,
which cannot be ﬁlled by DNA polymerases due to the strict
50?30 polarity of their synthesis activity. Consequently, in the ab-
sence of a prophylactic mechanism, continuous cycles of replica-
tion would cause the genomes of individual organisms to grow
progressively shorter and genes would be lost [140]. The additionof telomeres, non-coding repetitive DNA sequences, to the termini
of chromosomes overcomes this problem. Telomerase, a special-
ized reverse transcriptase that carries its own RNA template, syn-
thesizes telomeres of sufﬁcient size to ensure that genetic
information is not lost due to the end replication problem. After
telomerase has synthesized a guanine-rich 30 single-stranded
extension (composed of TTAGGG repeats in humans) at the chro-
mosome terminus, the cytosine-rich complementary strand is syn-
thesized by traditional semi-conservative replication. In yeast,
telomerase is active at each round of DNA replication, thereby
ensuring that telomere length maintains a steady state. In contrast,
during vertebrate development and within stem cell populations,
telomerase synthesizes telomeres with a length that is sufﬁcient
to sustain numerous future replication cycles. Since telomerase is
inactive in somatic cells, telomeres grow progressively shorter over
time until they reach a critical length, at which point cell senes-
cence or apoptosis is triggered. Vertebrate telomeres therefore pro-
vide a solution to the end replication problem in a temporally ﬁnite
manner. This brings the added beneﬁt of tumor suppression, in
that unchecked cellular replication associated with cancer is
thwarted when these cells reach their critical telomere length.
Throughout Eukarya, telomeres are bound by speciﬁc proteins
that sequester the free chromosome termini within a nucleopro-
tein cap [141]. In higher eukaryotes these same telomere-binding
proteins additionally promote the formation of a unique lariat-like
structure called the ‘‘t-loop”, which provides a second layer of pro-
tection from the DSB repair machinery [140,142]. Critical to t-loop
formation is the generation of a 30 single-stranded overhang
(termed the ‘‘G-overhang” because it is present on the G-rich
strand of the telomere) at each chromosome terminus. Since the
newly synthesized lagging strand is missing a portion of its 50 ter-
minus, a short 30 G-overhang (10 nucleotides) is inherently pres-
ent at this end of a newly synthesized chromosome. In contrast,
leading strand synthesis generates a blunt chromosome end. In
higher eukaryotes both this blunt end and the short G-overhang
at the opposite chromosome end are processed by an unknown
nuclease to generate mature G-overhangs 50–300 nucleotides in
length [140]. Folding each chromosome terminus back upon itself
enables the G-overhang to invade and base pair with the comple-
mentary strand (analogous to what occurs during HR), giving rise
to the t-loop lariat (Fig. 3). Although G-overhangs are also present
at telomeres in S. cerevisiae, they are only 12–14 nucleotides in
length [143] and t-loops have not been observed. Regardless of
whether or not t-loops are employed, the importance of sequester-
ing telomeres into nucleoprotein caps is made clear by the fact that
cap disruption can result in shortening or lengthening of telo-
meres, telomere fusion, telomere loss, elevated levels of recombi-
nation, and checkpoint activation [144].
In vertebrates stabilization of telomeres and formation of the t-
loop are facilitated by the shelterin complex, which consists of the
following six proteins: Telomeric Repeat-binding Factors 1 and 2
(TRF1 and TRF2), repressor and activator protein 1 (RAP1), TRF1-
interacting nuclear protein 2 (TIN2), protection of telomeres 1
(POT1), and TIN2- and POT1-interacting protein (TPP1) [141].
Whereas TRF1 and TRF2 bind the double-stranded region of the
telomere, POT1 has afﬁnity speciﬁcally for the single-stranded G-
overhang (Fig. 3). TIN2 bridges TRF1 and TRF2, while TPP1 bridges
TIN2 and POT1. RAP1 is recruited to telomeres via its interaction
with TRF2 [140]. Details regarding the vertebrate shelterin com-
plex, its homologs in other organisms, and other facets of telomere
structure and function are examined elsewhere in this issue.
The importance of the MRX complex for normal telomere main-
tenance was ﬁrst recognized many years ago when deletion or dis-
ruption of S. cerevisiae Rad50 [145], Mre11, or Xrs2 [146] were
reported to result in shortened telomeres and cell senescence
[147]. Lundblad and co-workers subsequently demonstrated MRX
Fig. 3. Human telomere structure. Speciﬁc interactions between shelterin components, and between these proteins and speciﬁc regions of telomeric DNA are highlighted.
Looping back the 30 G-overhang enables it to invade distal, duplex regions of the telomere and base pair with the complementary C-rich strand, giving rise to the t-loop
structure. See text for details.
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Consistent with this notion, S. cerevisiae MRX associates with telo-
meres in late S-phase [149] when yeast telomeres are synthesized,
and in the absence of functional MRX the single-stranded telomeric
DNA binding protein Cdc13 is unable to bind to telomeres
[149,150]. Multiple groups have independently demonstrated that
in both S. cerevisiae and S. pombe telomere length [151] and the
speciﬁc formation of G-overhangs [149,152] are unaffected by
the nuclease-inactivating D56N or H125N mutations of Mre11.
Moreover, telomerase-mediated replication of telomeres is defec-
tive in Mre11 null cells but not in the Mre11-D56N or Mre11-
H125N backgrounds [153]. Targeting S. cerevisiae telomerase to
telomeres via fusion with Cdc13 overcomes telomere maintenance
defects resulting from a non-functional MRX complex [153]. Col-
lectively, these observations suggest that MRX facilitates the
recruitment of telomerase to telomeres. Consistent with this, in
S. cerevisiae the speciﬁc recruitment of telomerase to telomeres
during the S phase is abolished by the absence of Mre11 [149].
While the MRX-mediated recruitment of yeast telomerase to telo-
meres could involve a direct interaction between these proteins, it
could also simply be a consequence of MRX promoting the process-
ing of telomeres into a form suitable for telomerase sequestration.
Considering the well established role of MRX as a promoter of
50?30 resection at DSBs, the speciﬁcity of Cdc13 for ssDNA, and
the afﬁnity of Cdc13 for telomerase, it is tempting to speculate that
MRX works with Sae2 to generate short 30 overhangs that are
bound by Cdc13 and subsequently recruit telomerase.
The ﬁrst indication that MRN may also contribute to telomere
maintenance in higher eukaryotes was the identiﬁcation of Nbs1
and Mre11 sequestered at telomeres in meiotic human ﬁbroblasts
[154]. It was subsequently shown that MRN speciﬁcally associates
with the TRF2 component of shelterin, and that Nbs1 accumulatesat telomeres in S phase but not during G1 or G2 [155]. Since TRF2
does not associate with ionizing radiation-induced DSBs, this inter-
action appears to occur exclusively within the telomere micro-
environment.
Cultured human NBS ﬁbroblasts display shortened telomeres. In
these cells, the coexpression of Nbs1 along with telomerase results
in longer telomeres than the expression of telomerase alone [156].
This suggests that, analogous to the situation in yeast, human MRN
facilitates telomerase activity at telomeres. Further supporting this
notion, knockdown of Mre11 or Nbs1 in cultured human cancer
cells speciﬁcally reduces the length of 30 G-overhangs, but has no
effect in cells that do not express telomerase [157]. Collectively,
these data demonstrate that MRN facilitates the action of telome-
rase at chromosome termini in mammalian cells. Whether MRN
facilitates telomerase activity by modifying telomere ends, open-
ing up the t-loop, altering chromatin structure, or by directly asso-
ciating with telomerase remains to be determined. In telomerase-
negative primary human cells, chromatin immuno-precipitation
revealed that Mre11, phosphorylated Nbs1, and ATM were bound
to telomeres in the G2 phase of the cell cycle [158]. This study sug-
gested that telomeres become accessible in G2 and are recognized
as DNA damage. A localized DNA damage response at telomeres
may therefore be required for recruiting the processing machinery
that is responsible for formation of the end protection complex.
Telomeres can be rendered dysfunctional by removal of the
telomere DNA binding protein TRF2 from the shelterin complex.
These ‘‘uncapped” telomeres are recognized as DSBs, and result
in ATM activation, phosphorylation of Chk2 and H2AX, the forma-
tion of 53BP1-associated telomere-induced DNA damage foci (TIF),
and NHEJ-mediated chromosome fusion [159]. The role of MRN at
dysfunctional telomeres has recently been studied in embryonic
ﬁbroblasts derived from mice harboring MRN mutations and
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shRNA knockdown [160–162]. These studies demonstrate that
MRN is required for ATM signaling in response to telomere dys-
function. When TRF2 levels are depleted by shRNA, ATM activation
and TIF formation are reduced in the Mre11D/D null background
but remain robust in the nuclease deﬁcient Mre11H129N/D back-
ground [162]. This suggests that the MRN complex functions to de-
tect and signal the presence of dysfunctional uncapped telomeres,
and that this capability does not depend on the Mre11 nuclease
activity.
Studies of dysfunctional telomeres performed in TRF2 deﬁcient
cells, have revealed a complex role for MRN in telomere fusion by
NHEJ. Depending on the stage of the cell cycle and the speciﬁc
structure of the telomere terminus, MRN can either promote or
suppress the NHEJ-mediated fusion of dysfunctional telomeres.
Conditional double-knockout of Nbs1 and TRF2 results in abro-
gated fusions in G1, due to defects in ATM-dependent signaling
[161]. Although in G1 the MRN complex may promote NHEJ,
the role of MRN after replication in G2 appears to be very differ-
ent [161], and here the ability of MRN to promote end-to-end
chromosome fusions at uncapped telomeres depends on Mre11’s
nuclease activity [162]. In another study employing TRF2 knock-
down cells, the number of chromosome fusions in the Mre11D/D
and Mre11H129N/D backgrounds was 15-fold lower than that
observed in an Mre11 active background [162]. To test whether
Mre11 promotes NHEJ of TRF2-uncapped telomeres by removing
the 30 G-overhang, an in-gel hybridization assay was employed.
In contrast to cells with functional Mre11 where the 30 overhang
is rapidly degraded, in Mre11D/D and Mre11H129N/D cells the over-
hang persists [162]. This suggests that the Mre11 nuclease activ-
ity is required for processing of 30 overhangs to allow efﬁcient
NHEJ of telomere ends when rendered dysfunctional by TRF2
removal. An especially illuminating ﬁnding of these TRF2-un-
capped telomere studies was that even though they occurred
much less frequently, telomere–telomere fusions still occurred
in the absence of functional MRN [160–162]. Importantly, the
majority (90%) of these residual telomere fusions involved the
leading strands of sister chromatids. In the Mre11H129N/D back-
ground only 60% of telomere–telomere fusions involved the
leading strands of sister chromatids [162]. The authors suggested
that this can be explained by the structural differences between
telomere termini generated by leading versus lagging-strand
replication. Leading-strand replication generates a blunt-ended
telomere terminus that can readily be fused via NHEJ without
prior nuclease processing. In contrast, lagging-strand replication
generates a 30 telomeric overhang, which is incompatible with
DNA ligation [159] and would therefore require nuclease process-
ing prior to fusion. Thus, within a TRF2 deﬁcient background the
MRN complex appears to prevent the fusion of newly replicated
leading strand telomeres by promoting 50 end resection to give
NHEJ-incompatible 30 overhangs. It will be interesting to deter-
mine the extent to which CtIP and other end-processing factors
are involved here.
The cellular response to dysfunctional telomeres is in many
ways similar to the response induced by non-telomeric DSBs. In
both of these contexts MRN is required for ATM activation, and
many of the factors that accumulate at ionizing radiation-induced
foci (IRIF) also accumulate at TIF. Moreover, both damage-induced
DSBs and dysfunctional telomeres can lead to the same signaling
pathways, cell cycle arrest, and apoptosis [163,164]. Differences
between damage-induced DSBs and uncapped telomeres include
(i) the fact that TRF2 suppresses ATM activation only within the
telomere micro-environment since it is abundant at chromosome
ends but not elsewhere in the nucleus [165], and (ii) DNA process-
ing is not required for the ATM-mediated damage response at
telomeres [159].6. MRN and exogenous DNA
In addition to the situation at the termini of linear eukaryotic
chromosomes, the issues of end recognition and protection also
emerge when exogenous extra-chromosomal DNA is encountered
in the nucleus. For example, when the genome of a linear DNA
virus is delivered to the nucleus of an infected cell it may be per-
ceived as a DSB, and therefore has the potential to trigger the
endogenous DNA damage response [166]. Some viruses have
therefore evolved elaborate schemes to ensure that detrimental
processing of their genomic termini does not take place during vir-
al replication. In addition to its role as a sensor of cellular DNA
ends, the MRN complex has emerged as a detector of viral gen-
omes, with a central role in the cellular response to viral DNA
[166]. This ability of the MRN complex to detect DNA ends can
be either beneﬁcial or detrimental to the virus lifecycle.
One of the ﬁrst examples of a virus that interacts with the MRN
complex came from the dsDNA virus Adenovirus. It has been sug-
gested that one way the linear Adenovirus genome is protected is
through virally-encoded proteins that induce the degradation and
mislocalization of components of the cellular DNA damage
machinery, including the MRN complex [167]. Mutants of Adenovi-
rus unable to attenuate functions of the MRN complex are defec-
tive in viral replication and progeny production [168–171]. One
phenotype of these mutant viruses is that the viral genome is li-
gated into concatamers through end-to-end joining in a process
that requires both MRN and NHEJ factors [167,172]. During infec-
tion with Adenovirus mutants unable to inactivate the MRN com-
plex, the cellular DNA damage signaling responses are also
activated [69]. Attenuation of signaling and checkpoint activation
by viral proteins that degrade or mislocalize MRN demonstrated
upstream functions of this complex in both ATM and ATR signaling
pathways [69,90]. The termini of the Adenovirus genome are also
protected by a covalently-attached, virally-encoded terminal pro-
tein, which is important for initiation of viral DNA replication.
We have suggested that removal of this protein from the end of
the viral genome is analogous to removal of Spo11 from DSBs dur-
ing meiotic recombination [167], and we propose that the com-
bined action of the MRN complex together with CtIP is required
for processing of the protein-blocked ends.
Beyond Adenovirus, the MRN complex has been implicated in
the response tomany different viruses [166]. It is found at viral rep-
lication centers during the early stages of SV40 infection, and com-
ponents of the complex may be speciﬁcally downregulated late
during infection in an ATM-dependent manner [173]. Nbs1 was
shown to interact with the SV40 encoded T-antigen, leading to
the discovery that Nbs1 can suppress rereplication of genomes dur-
ing S phase [174]. TheMRN complex is also found at virally-induced
replication centers in the nuclei of cells infected by many different
viruses. For example, MRN is present within the globular compart-
ments formed during HSV-1 infection, and in this exampleMre11 is
beneﬁcial to the early stages of viral replication [175]. There is also
evidence that MRNmay be downregulated late during HSV-1 infec-
tion, similar to the scenario with SV40 [176]. In addition to activa-
tion of signaling in response to viral genetic material, the MRN
complex also plays a role in circularization, episomal maintenance
and integration of viral genomes. These studies of theMRN complex
in the context of virus infection have revealed its role as part of an
anti-viral defense and have highlighted ways in which cellular re-
pair pathways can be exploited by invading genomes [166].
7. Conclusion
The MRN complex sits at a central position in a complex net-
work that senses, signals, and ultimately facilitates repair of DNA
damage. It has crucial roles as a sensor of DSBs, and in activating
3692 B.J. Lamarche et al. / FEBS Letters 584 (2010) 3682–3695the signal transduction cascades that lead to cell cycle checkpoints.
It also plays pivotal roles in regulating repair pathway selection, as
well as the actual DNA repair processes of both NHEJ and HR. A
better understanding of the activities of this multifaceted complex
will explain the requirements for maintaining genomic integrity,
and the malignancies that arise in patients with genome instability
disorders. This will also open up new opportunities to consider
chemical ways to disrupt speciﬁc branches of the pathways con-
trolled by MRN, and in this way sensitize tumor cells to DNA dam-
aging cancer therapeutics. A forward chemical genetic screen has
already identiﬁed an inhibitor of MRN that prevents MRN-depen-
dent activation of ATM, the G2/M checkpoint, and homology-direc-
ted repair in mammalian cells [177].
The equilibrium between telomere function and dysfunction
depends on a large number of factors, and the roles of MRN in this
balance are only just beginning to be elucidated. While MRN can
promote telomere function by recruiting telomerase to properly
capped telomeres and by preventing the fusion of newly replicated
leading strand telomeres, it can also exacerbate telomere dysfunc-
tion by degrading the G-overhang and thereby promoting telomere
fusion. The dual functions of MRN in DNA processing and activa-
tion of damage signaling, are evident in its response to both geno-
mic DSBs and telomeres. The importance of MRN to telomere
metabolism has been demonstrated in a wide range of organisms,
including S. pombe, Kluyveromyces lactis, Arabidopsis thaliana, Dro-
sophila melanogaster, and Homo sapiens. Differences between these
systems may be exploited to generate a detailed model of MRN
function at telomeres, and will help us to navigate the complicated
relationship between telomeres and the DNA damage machinery.
Acknowledgements
We apologize to the many groups whose primary research pa-
pers could not be cited due to space constraints. We thank our col-
leagues in the ﬁeld of DNA repair for helpful discussions and
members of the Weitzman lab for comments on the manuscript.
Work on the MRN complex in the Weitzman lab has been sup-
ported by grants from the National Institutes of Health
(AI067952, CA097093 and AI051686) and a Pioneer Developmental
Chair from the Salk Institute. B.J.L. is supported by a postdoctoral
Ruth L. Kirschstein National Research Service Award (NIH/NCI
T32 CA009523) and N.I.O. is supported in part by a gift from the
H.A. & Mary K. Chapman Charitable Trust.
References
[1] Shrivastav, M., De Haro, L.P. and Nickoloff, J.A. (2008) Regulation of DNA
double-strand break repair pathway choice. Cell Res. 18, 134–147.
[2] Bernstein, K.A. and Rothstein, R. (2009) At loose ends: resecting a double-
strand break. Cell 137, 807–810.
[3] Taylor, E.M., Cecillon, S.M., Bonis, A., Chapman, J.R., Povirk, L.F. and Lindsay,
H.D. (2010) The Mre11/Rad50/Nbs1 complex functions in resection-based
DNA end joining in Xenopus laevis. Nucleic Acids Res. 38, 441–454.
[4] Rass, E., Grabarz, A., Plo, I., Gautier, J., Bertrand, P. and Lopez, B.S. (2009) Role
of Mre11 in chromosomal nonhomologous end joining in mammalian cells.
Nat. Struct. Mol. Biol. 16, 819–824.
[5] Xie, A., Kwok, A. and Scully, R. (2009) Role of mammalian Mre11 in classical
and alternative nonhomologous end joining. Nat. Struct. Mol. Biol. 16, 814–
818.
[6] Dinkelmann, M., Spehalski, E., Stoneham, T., Buis, J., Wu, Y., Sekiguchi, J.M.
and Ferguson, D.O. (2009) Multiple functions of MRN in end-joining
pathways during isotype class switching. Nat. Struct. Mol. Biol. 16, 808–813.
[7] Zha, S., Boboila, C. and Alt, F.W. (2009) Mre11: roles in DNA repair beyond
homologous recombination. Nat. Struct. Mol. Biol. 16, 798–800.
[8] Ogawa, H., Johzuka, K., Nakagawa, T., Leem, S.H. and Hagihara, A.H. (1995)
Functions of the yeast meiotic recombination genes, MRE11 and MRE2. Adv.
Biophys. 31, 67–76.
[9] Usui, T., Ohta, T., Oshiumi, H., Tomizawa, J., Ogawa, H. and Ogawa, T. (1998)
Complex formation and functional versatility of Mre11 of budding yeast in
recombination. Cell 95, 705–716.
[10] Dolganov, G.M., Maser, R.S., Novikov, A., Tosto, L., Chong, S., Bressan, D.A. and
Petrini, J.H. (1996) Human Rad50 is physically associated with humanMre11: identiﬁcation of a conserved multiprotein complex implicated in
recombinational DNA repair. Mol. Cell Biol. 16, 4832–4841.
[11] Trujillo, K.M., Yuan, S.S., Lee, E.Y. and Sung, P. (1998) Nuclease activities in a
complex of human recombination and DNA repair factors Rad50, Mre11, and
p95. J. Biol. Chem. 273, 21447–21450.
[12] Hopkins, B.B. and Paull, T.T. (2008) The P. furiosus mre11/rad50 complex
promotes 5’ strand resection at a DNA double-strand break. Cell 135, 250–
260.
[13] Williams, R.S., Williams, J.S. and Tainer, J.A. (2007) Mre11-Rad50-Nbs1 is a
keystone complex connecting DNA repair machinery, double-strand break
signaling, and the chromatin template. Biochem. Cell Biol. 85, 509–520.
[14] D’Amours, D. and Jackson, S.P. (2002) The Mre11 complex: at the crossroads
of DNA repair and checkpoint signalling. Nat. Rev. Mol. Cell Biol. 3, 317–327.
[15] Williams, R.S. et al. (2008) Mre11 dimers coordinate DNA end bridging and
nuclease processing in double-strand-break repair. Cell 135, 97–109.
[16] de Jager, M., Dronkert, M.L., Modesti, M., Beerens, C.E., Kanaar, R. and van
Gent, D.C. (2001) DNA-binding and strand-annealing activities of human
Mre11: implications for its roles in DNA double-strand break repair
pathways. Nucleic Acids Res. 29, 1317–1325.
[17] Paull, T.T. and Gellert, M. (1999) Nbs1 potentiates ATP-driven DNA
unwinding and endonuclease cleavage by the Mre11/Rad50 complex.
Genes Dev. 13, 1276–1288.
[18] Paull, T.T. and Gellert, M. (1998) The 30 to 50 exonuclease activity of Mre 11
facilitates repair of DNA double-strand breaks. Mol. Cell 1, 969–979.
[19] Zhuang, J., Jiang, G., Willers, H. and Xia, F. (2009) Exonuclease function of
human Mre11 promotes deletional nonhomologous end joining. J. Biol.
Chem. 284, 30565–30573.
[20] Milman, N., Higuchi, E. and Smith, G.R. (2009) Meiotic DNA double-strand
break repair requires two nucleases, MRN and Ctp1, to produce a single size
class of Rec12 (Spo11)-oligonucleotide complexes. Mol. Cell Biol. 29, 5998–
6005.
[21] Farah, J.A., Cromie, G.A. and Smith, G.R. (2009) Ctp1 and exonuclease 1,
alternative nucleases regulated by the MRN complex, are required for
efﬁcient meiotic recombination. Proc. Natl. Acad. Sci. USA 106, 9356–9361.
[22] Mimitou, E.P. and Symington, L.S. (2009) DNA end resection: many nucleases
make light work. DNA Repair (Amst) 8, 983–995.
[23] van der Linden, E., Sanchez, H., Kinoshita, E., Kanaar, R. and Wyman, C. (2009)
RAD50 and NBS1 form a stable complex functional in DNA binding and
tethering. Nucleic Acids Res. 37, 1580–1588.
[24] Stewart, G.S. et al. (1999) The DNA double-strand break repair gene hMRE11
is mutated in individuals with an ataxia-telangiectasia-like disorder. Cell 99,
577–587.
[25] Zhong, H., Bryson, A., Eckersdorff, M. and Ferguson, D.O. (2005) Rad50
depletion impacts upon ATR-dependent DNA damage responses. Hum. Mol.
Genet. 14, 2685–2693.
[26] Hopfner, K.P., Karcher, A., Shin, D.S., Craig, L., Arthur, L.M., Carney, J.P. and
Tainer, J.A. (2000) Structural biology of Rad50 ATPase: ATP-driven
conformational control in DNA double-strand break repair and the ABC-
ATPase superfamily. Cell 101, 789–800.
[27] Hopfner, K.P., Karcher, A., Craig, L., Woo, T.T., Carney, J.P. and Tainer, J.A.
(2001) Structural biochemistry and interaction architecture of the DNA
double-strand break repair Mre11 nuclease and Rad50-ATPase. Cell 105,
473–485.
[28] de Jager, M., van Noort, J., van Gent, D.C., Dekker, C., Kanaar, R. andWyman, C.
(2001) Human Rad50/Mre11 is a ﬂexible complex that can tether DNA ends.
Mol. Cell 8, 1129–1135.
[29] Hopfner, K.P. et al. (2002) The Rad50 zinc-hook is a structure joining Mre11
complexes in DNA recombination and repair. Nature 418, 562–566.
[30] Cahill, D. and Carney, J.P. (2007) Dimerization of the Rad50 protein is
independent of the conserved hook domain. Mutagenesis 22, 269–274.
[31] Wiltzius, J.J., Hohl, M., Fleming, J.C. and Petrini, J.H. (2005) The Rad50 hook
domain is a critical determinant of Mre11 complex functions. Nat. Struct.
Mol. Biol. 12, 403–407.
[32] Lloyd, J. et al. (2009) A supramodular FHA/BRCT-repeat architecture mediates
Nbs1 adaptor function in response to DNA damage. Cell 139, 100–111.
[33] Williams, R.S. et al. (2009) Nbs1 ﬂexibly tethers Ctp1 and Mre11-Rad50 to
coordinate DNA double-strand break processing and repair. Cell 139, 87–99.
[34] Desai-Mehta, A., Cerosaletti, K.M. and Concannon, P. (2001) Distinct
functional domains of nibrin mediate Mre11 binding, focus formation, and
nuclear localization. Mol. Cell Biol. 21, 2184–2191.
[35] Falck, J., Coates, J. and Jackson, S.P. (2005) Conserved modes of recruitment of
ATM, ATR and DNA-PKcs to sites of DNA damage. Nature 434, 605–611.
[36] You, Z., Chahwan, C., Bailis, J., Hunter, T. and Russell, P. (2005) ATM activation
and its recruitment to damaged DNA require binding to the C terminus of
Nbs1. Mol. Cell Biol. 25, 5363–5379.
[37] Stracker, T.H., Morales, M., Couto, S.S., Hussein, H. and Petrini, J.H.J. (2007)
The carboxy terminus of NBS1 is required for induction of apoptosis by the
MRE11 complex. Nature 447, 218–221.
[38] Carney, J.P. et al. (1998) The hMre11/hRad50 protein complex and Nijmegen
breakage syndrome: linkage of double-strand break repair to the cellular
DNA damage response. Cell 93, 477–486.
[39] Varon, R. et al. (1998) Nibrin, a novel DNA double-strand break repair
protein, is mutated in Nijmegen breakage syndrome. Cell 93, 467–476.
[40] Antoccia, A., Kobayashi, J., Tauchi, H., Matsuura, S. and Komatsu, K. (2006)
Nijmegen breakage syndrome and functions of the responsible protein, NBS1.
Genome Dyn. 1, 191–205.
B.J. Lamarche et al. / FEBS Letters 584 (2010) 3682–3695 3693[41] Taylor, A.M., Groom, A. and Byrd, P.J. (2004) Ataxia-telangiectasia-like
disorder (ATLD)-its clinical presentation and molecular basis. DNA Repair
(Amst) 3, 1219–1225.
[42] Waltes, R. et al. (2009) Human RAD50 deﬁciency in a Nijmegen breakage
syndrome-like disorder. Am. J. Hum. Genet. 84, 605–616.
[43] Dzikiewicz-Krawczyk, A. (2008) The importance of making ends meet:
mutations in genes and altered expression of proteins of the MRN complex
and cancer. Mutat. Res. 659, 262–273.
[44] Theunissen, J.-W.F., Kaplan, M.I., Hunt, P.A., Williams, B.R., Ferguson, D.O., Alt,
F.W. and Petrini, J.H.J. (2003) Checkpoint failure and chromosomal instability
without lymphomagenesis in Mre11(ATLD1/ATLD1) mice. Mol. Cell 12,
1511–1523.
[45] Kang, J., Bronson, R.T. and Xu, Y. (2002) Targeted disruption of NBS1 reveals
its roles in mouse development and DNA repair. EMBO J. 21, 1447–1455.
[46] Diﬁlippantonio, S. et al. (2005) Role of Nbs1 in the activation of the Atm
kinase revealed in humanized mouse models. Nat. Cell Biol. 7, 675–685.
[47] Diﬁlippantonio, S. et al. (2007) Distinct domains in Nbs1 regulate irradiation-
induced checkpoints and apoptosis. J. Exp. Med. 204, 1003–1011.
[48] Bender, C.F. et al. (2002) Cancer predisposition and hematopoietic failure in
Rad50(S/S) mice. Genes Dev. 16, 2237–2251.
[49] Kracker, S. et al. (2005) Nibrin functions in Ig class-switch recombination.
Proc. Natl. Acad. Sci. USA 102, 1584–1589.
[50] Frappart, P.-O., Tong, W.-M., Demuth, I., Radovanovic, I., Herceg, Z., Aguzzi, A.,
Digweed, M. and Wang, Z.-Q. (2005) An essential function for NBS1 in the
prevention of ataxia and cerebellar defects. Nat. Med. 11, 538–544.
[51] Reina-San-Martin, B., Nussenzweig, M.C., Nussenzweig, A. and
Diﬁlippantonio, S. (2005) Genomic instability, endoreduplication, and
diminished Ig class-switch recombination in B cells lacking Nbs1. Proc.
Natl. Acad. Sci. USA 102, 1590–1595.
[52] Williams, B.R., Mirzoeva, O.K., Morgan, W.F., Lin, J., Dunnick, W. and Petrini, J.H.J.
(2002) Amurinemodel of Nijmegen breakage syndrome. Curr. Biol. 12, 648–653.
[53] Luo, G., Yao, M.S., Bender, C.F., Mills, M., Bladl, A.R., Bradley, A. and Petrini, J.H.
(1999) Disruption of mRad50 causes embryonic stem cell lethality, abnormal
embryonic development, and sensitivity to ionizing radiation. Proc. Natl.
Acad. Sci. USA 96, 7376–7381.
[54] Cherry, S.M., Adelman, C.A., Theunissen, J.W., Hassold, T.J., Hunt, P.A. and
Petrini, J.H. (2007) The Mre11 complex inﬂuences DNA repair, synapsis, and
crossing over in murine meiosis. Curr. Biol. 17, 373–378.
[55] Frappart, P.O. and McKinnon, P.J. (2006) Ataxia-telangiectasia and related
diseases. Neuromol. Med. 8, 495–511.
[56] Baranes, K. et al. (2009) Conditional inactivation of the NBS1 gene in the
mouse central nervous system leads to neurodegeneration and
disorganization of the visual system. Exp. Neurol. 218, 24–32.
[57] Shull, E.R.P., Lee, Y., Nakane, H., Stracker, T.H., Zhao, J., Russell, H.R., Petrini,
J.H.J. and McKinnon, P.J. (2009) Differential DNA damage signaling accounts
for distinct neural apoptotic responses in ATLD and NBS. Genes Dev. 23, 171–
180.
[58] Lavin, M.F. (2007) ATM and the Mre11 complex combine to recognize and
signal DNA double-strand breaks. Oncogene 26, 7749–7758.
[59] Borde, V. and Cobb, J. (2009) Double functions for the Mre11 complex during
DNA double-strand break repair and replication. Int. J. Biochem. Cell Biol. 41,
1249–1253.
[60] Borde, V. (2007) The multiple roles of the Mre11 complex for meiotic
recombination. Chromosome Res. 15, 551–563.
[61] Jackson, S.P. and Bartek, J. (2009) The DNA-damage response in human
biology and disease. Nature 461, 1071–1078.
[62] Harper, J.W. and Elledge, S.J. (2007) The DNA damage response: ten years
after. Mol. Cell 28, 739–745.
[63] Rogakou, E.P., Pilch, D.R., Orr, A.H., Ivanova, V.S. and Bonner, W.M. (1998)
DNA double-stranded breaks induce histone H2AX phosphorylation on serine
139. J. Biol. Chem. 273, 5858–5868.
[64] Dickey, J.S., Redon, C.E., Nakamura, A.J., Baird, B.J., Sedelnikova, O.A. and
Bonner, W.M. (2009) H2AX: functional roles and potential applications.
Chromosoma 118, 683–692.
[65] Schleker, T., Nagai, S. and Gasser, S.M. (2009) Posttranslational modiﬁcations
of repair factors and histones in the cellular response to stalled replication
forks. DNA Repair (Amst) 8, 1089–1100.
[66] Huen, M.S. and Chen, J. (2008) The DNA damage response pathways: at the
crossroad of protein modiﬁcations. Cell Res. 18, 8–16.
[67] Matsuoka, S. et al. (2007) ATM and ATR substrate analysis reveals extensive
protein networks responsive to DNA damage. Science 316, 1160–1166.
[68] Petrini, J.H. and Stracker, T.H. (2003) The cellular response to DNA double-
strand breaks: deﬁning the sensors and mediators. Trends Cell Biol. 13, 458–
462.
[69] Carson, C.T., Schwartz, R.A., Stracker, T.H., Lilley, C.E., Lee, D.V. andWeitzman,
M.D. (2003) The Mre11 complex is required for ATM activation and the G2/M
checkpoint. EMBO J. 22, 6610–6620.
[70] Girard, P.M., Riballo, E., Begg, A.C., Waugh, A. and Jeggo, P.A. (2002) Nbs1
promotes ATM dependent phosphorylation events including those required
for G1/S arrest. Oncogene 21, 4191–4199.
[71] Uziel, T., Lerenthal, Y., Moyal, L., Andegeko, Y., Mittelman, L. and Shiloh, Y.
(2003) Requirement of the MRN complex for ATM activation by DNA damage.
EMBO J. 22, 5612–5621.
[72] Maser, R.S., Monsen, K.J., Nelms, B.E. and Petrini, J.H. (1997) HMre11 and
hRad50 nuclear foci are induced during the normal cellular response to DNA
double-strand breaks. Mol. Cell Biol. 17, 6087–6096.[73] Mirzoeva, O.K. and Petrini, J.H. (2001) DNA damage-dependent nuclear
dynamics of the Mre11 complex. Mol. Cell Biol. 21, 281–288.
[74] Nelms, B.E., Maser, R.S., MacKay, J.F., Lagally, M.G. and Petrini, J.H. (1998) In
situ visualization of DNA double-strand break repair in human ﬁbroblasts.
Science 280, 590–592.
[75] Paull, T.T., Rogakou, E.P., Yamazaki, V., Kirchgessner, C.U., Gellert, M. and
Bonner, W.M. (2000) A critical role for histone H2AX in recruitment of repair
factors to nuclear foci after DNA damage. Curr. Biol. 10, 886–895.
[76] Lukas, C., Falck, J., Bartkova, J., Bartek, J. and Lukas, J. (2003) Distinct
spatiotemporal dynamics of mammalian checkpoint regulators induced by
DNA damage. Nat. Cell Biol. 5, 255–260.
[77] Bakkenist, C.J. and Kastan, M.B. (2003) DNA damage activates ATM through
intermolecular autophosphorylation and dimer dissociation. Nature 421,
499–506.
[78] Lee, J.H., Goodarzi, A.A., Jeggo, P.A. and Paull, T.T. (2010) 53BP1 promotes
ATM activity through direct interactions with the MRN complex. EMBO J. 29,
574–585.
[79] So, S., Davis, A.J. and Chen, D.J. (2009) Autophosphorylation at serine 1981
stabilizes ATM at DNA damage sites. J. Cell Biol. 187, 977–990.
[80] Lee, J.H. and Paull, T.T. (2005) ATM activation by DNA double-strand breaks
through the Mre11–Rad50–Nbs1 complex. Science 308, 551–554.
[81] Berkovich, E., Monnat Jr., R.J. and Kastan, M.B. (2007) Roles of ATM and NBS1
in chromatin structure modulation and DNA double-strand break repair. Nat.
Cell Biol. 9, 683–690.
[82] Kitagawa, R., Bakkenist, C.J., McKinnon, P.J. and Kastan, M.B. (2004)
Phosphorylation of SMC1 is a critical downstream event in the ATM–NBS1–
BRCA1 pathway. Genes Dev. 18, 1423–1438.
[83] Lee, J.S. (2007) Activation of ATM-dependent DNA damage signal pathway by
a histone deacetylase inhibitor, trichostatin A. Cancer Res. Treat. 39, 125–
130.
[84] Jang, E.R., Choi, J.D., Park, M.A., Jeong, G., Cho, H. and Lee, J.S. (2010) ATM
modulates transcription in response to histone deacetylase inhibition as part
of its DNA damage response. Exp. Mol. Med. 42, 195–204.
[85] Sun, Y., Jiang, X. and Price, B.D. (2010) Tip60: connecting chromatin to DNA
damage signaling. Cell Cycle 9, 930–936.
[86] Kanu, N. and Behrens, A. (2008) ATMINistrating ATM signalling: regulation of
ATM by ATMIN. Cell Cycle 7, 3483–3486.
[87] Jazayeri, A., Falck, J., Lukas, C., Bartek, J., Smith, G.C., Lukas, J. and Jackson, S.P.
(2006) ATM- and cell cycle-dependent regulation of ATR in response to DNA
double-strand breaks. Nat. Cell Biol. 8, 37–45.
[88] Shiotani, B. and Zou, L. (2009) Single-stranded DNA orchestrates an ATM-to-
ATR switch at DNA breaks. Mol. Cell 33, 547–558.
[89] Buis, J. et al. (2008) Mre11 nuclease activity has essential roles in DNA repair
and genomic stability distinct from ATM activation. Cell 135, 85–96.
[90] Carson, C.T. et al. (2009) Mislocalization of the MRN complex prevents ATR
signaling during adenovirus infection. EMBO J. 28, 652–662.
[91] Manthey, K.C., Opiyo, S., Glanzer, J.G., Dimitrova, D., Elliott, J. and Oakley, G.G.
(2007) NBS1 mediates ATR-dependent RPA hyperphosphorylation following
replication-fork stall and collapse. J. Cell Sci. 120, 4221–4229.
[92] Olson, E., Nievera, C.J., Lee, A.Y.-L., Chen, L. and Wu, X. (2007) The Mre11–
Rad50–Nbs1 complex acts both upstream and downstream of ataxia
telangiectasia mutated and Rad3-related protein (ATR) to regulate the S-
phase checkpoint following UV treatment. J. Biol. Chem. 282, 22939–22952.
[93] Stiff, T., Reis, C., Alderton, G.K., Woodbine, L., O’Driscoll, M. and Jeggo, P.A.
(2005) Nbs1 is required for ATR-dependent phosphorylation events. EMBO J.
24, 199–208.
[94] Jazayeri, A., Balestrini, A., Garner, E., Haber, J.E. and Costanzo, V. (2008)
Mre11–Rad50–Nbs1-dependent processing of DNA breaks generates
oligonucleotides that stimulate ATM activity. EMBO J. 27, 1953–1962.
[95] Reinhardt, H.C. and Yaffe, M.B. (2009) Kinases that control the cell cycle in
response to DNA damage: Chk1, Chk2, and MK2. Curr. Opin. Cell Biol. 21,
245–255.
[96] Tsukuda, T., Fleming, A.B., Nickoloff, J.A. and Osley, M.A. (2005) Chromatin
remodelling at a DNA double-strand break site in Saccharomyces cerevisiae.
Nature 438, 379–383.
[97] Sun, Y., Jiang, X., Xu, Y., Ayrapetov, M.K., Moreau, L.A., Whetstine, J.R. and
Price, B.D. (2009) Histone H3 methylation links DNA damage detection to
activation of the tumour suppressor Tip60. Nat. Cell Biol. 11, 1376–1382.
[98] Conde, F., Refolio, E., Cordon-Preciado, V., Cortes-Ledesma, F., Aragon, L.,
Aguilera, A. and San-Segundo, P.A. (2009) The Dot1 histone
methyltransferase and the Rad9 checkpoint adaptor contribute to cohesin-
dependent double-strand break repair by sister chromatid recombination in
Saccharomyces cerevisiae. Genetics 182, 437–446.
[99] Galanty, Y., Belotserkovskaya, R., Coates, J., Polo, S., Miller, K.M. and Jackson,
S.P. (2009) Mammalian SUMO E3-ligases PIAS1 and PIAS4 promote responses
to DNA double-strand breaks. Nature 462, 935–939.
[100] Messick, T.E. and Greenberg, R.A. (2009) The ubiquitin landscape at DNA
double-strand breaks. J. Cell Biol. 187, 319–326.
[101] Mao, Z., Bozzella, M., Seluanov, A. and Gorbunova, V. (2008) Comparison of
nonhomologous end joining and homologous recombination in human cells.
DNA Repair (Amst) 7, 1765–1771.
[102] Aguilera, A. and Gomez-Gonzalez, B. (2008) Genome instability: a
mechanistic view of its causes and consequences. Nat. Rev. Genet. 9, 204–
217.
[103] Branzei, D. and Foiani, M. (2008) Regulation of DNA repair throughout the
cell cycle. Nat. Rev. Mol. Cell Biol. 9, 297–308.
3694 B.J. Lamarche et al. / FEBS Letters 584 (2010) 3682–3695[104] Hartlerode, A.J. and Scully, R. (2009) Mechanisms of double-strand break
repair in somatic mammalian cells. Biochem. J. 423, 157–168.
[105] Ding, D.Q., Haraguchi, T. and Hiraoka, Y. (2010) From meiosis to postmeiotic
events: alignment and recognition of homologous chromosomes in meiosis.
FEBS J. 277, 565–570.
[106] Huertas, P. (2010) DNA resection in eukaryotes: deciding how to ﬁx the
break. Nat. Struct. Mol. Biol. 17, 11–16.
[107] Aylon, Y., Liefshitz, B. and Kupiec, M. (2004) The CDK regulates repair of
double-strand breaks by homologous recombination during the cell cycle.
EMBO J. 23, 4868–4875.
[108] Ira, G. et al. (2004) DNA end resection, homologous recombination and DNA
damage checkpoint activation require CDK1. Nature 431, 1011–1017.
[109] Dynan, W.S. and Yoo, S. (1998) Interaction of Ku protein and DNA-dependent
protein kinase catalytic subunit with nucleic acids. Nucleic Acids Res. 26,
1551–1559.
[110] Zhang, Y., Shim, E.Y., Davis, M. and Lee, S.E. (2009) Regulation of repair
choice. Cdk1 suppresses recruitment of end joining factors at DNA breaks.
DNA Repair (Amst) 8, 1235–1241.
[111] Clerici, M., Mantiero, D., Lucchini, G. and Longhese, M.P. (2005) The
Saccharomyces cerevisiae Sae2 protein promotes resection and bridging of
double strand break ends. J. Biol. Chem. 280, 38631–38638.
[112] Lengsfeld, B.M., Rattray, A.J., Bhaskara, V., Ghirlando, R. and Paull, T.T. (2007)
Sae2 is an endonuclease that processes hairpin DNA cooperatively with the
Mre11/Rad50/Xrs2 complex. Mol. Cell 28, 638–651.
[113] Neale, M.J., Pan, J. and Keeney, S. (2005) Endonucleolytic processing of
covalent protein-linked DNA double-strand breaks. Nature 436, 1053–1057.
[114] Limbo, O., Chahwan, C., Yamada, Y., de Bruin, R.A., Wittenberg, C. and Russell,
P. (2007) Ctp1 is a cell-cycle-regulated protein that functions with Mre11
complex to control double-strand break repair by homologous
recombination. Mol. Cell 28, 134–146.
[115] Huertas, P. and Jackson, S.P. (2009) Human CtIP mediates cell cycle control of
DNA end resection and double strand break repair. J. Biol. Chem. 284, 9558–
9565.
[116] Sartori, A.A. et al. (2007) Human CtIP promotes DNA end resection. Nature
450, 509–514.
[117] You, Z. and Bailis, J.M. (2010) DNA damage and decisions: CtIP coordinates
DNA repair and cell cycle checkpoints. Trends Cell Biol. 20, 402–409.
[118] You, Z. et al. (2009) CtIP links DNA double-strand break sensing to resection.
Mol. Cell 36, 954–969.
[119] Mimitou, E.P. and Symington, L.S. (2008) Sae2, Exo1 and Sgs1 collaborate in
DNA double-strand break processing. Nature 455, 770–774.
[120] Zhu, Z., Chung, W.H., Shim, E.Y., Lee, S.E. and Ira, G. (2008) Sgs1 helicase and
two nucleases Dna2 and Exo1 resect DNA double-strand break ends. Cell 134,
981–994.
[121] Gravel, S., Chapman, J.R., Magill, C. and Jackson, S.P. (2008) DNA helicases
Sgs1 and BLM promote DNA double-strand break resection. Genes Dev. 22,
2767–2772.
[122] Yu, X. and Baer, R. (2000) Nuclear localization and cell cycle-speciﬁc
expression of CtIP, a protein that associates with the BRCA1 tumor
suppressor. J. Biol. Chem. 275, 18541–18549.
[123] Yun, M.H. and Hiom, K. (2009) CtIP-BRCA1 modulates the choice of DNA
double-strand-break repair pathway throughout the cell cycle. Nature 459,
460–463.
[124] Dodson, G.E., Limbo, O., Nieto, D. and Russell, P. (2010) Phosphorylation-
regulated binding of Ctp1 to Nbs1 is critical for repair of DNA double-strand
breaks. Cell Cycle 9, 1516–1522.
[125] Huertas, P., Cortes-Ledesma, F., Sartori, A.A., Aguilera, A. and Jackson, S.P.
(2008) CDK targets Sae2 to control DNA-end resection and homologous
recombination. Nature 455, 689–692.
[126] Kim, J.S., Krasieva, T.B., Kurumizaka, H., Chen, D.J., Taylor, A.M. and Yokomori,
K. (2005) Independent and sequential recruitment of NHEJ and HR factors to
DNA damage sites in mammalian cells. J. Cell Biol. 170, 341–347.
[127] Wasko, B.M., Holland, C.L., Resnick, M.A. and Lewis, L.K. (2009) Inhibition of
DNA double-strand break repair by the Ku heterodimer in mrx mutants of
Saccharomyces cerevisiae. DNA Repair (Amst) 8, 162–169.
[128] Fukushima, T. et al. (2001) Genetic analysis of the DNA-dependent protein
kinase reveals an inhibitory role of Ku in late S-G2 phase DNA double-strand
break repair. J. Biol. Chem. 276, 44413–44418.
[129] Clikeman, J.A., Khalsa, G.J., Barton, S.L. and Nickoloff, J.A. (2001) Homologous
recombinational repair of double-strand breaks in yeast is enhanced by MAT
heterozygosity through yKU-dependent and -independent mechanisms.
Genetics 157, 579–589.
[130] Zhang, Y. et al. (2007) Role of Dnl4-Lif1 in nonhomologous end-joining repair
complex assembly and suppression of homologous recombination. Nat.
Struct. Mol. Biol. 14, 639–646.
[131] Pierce, A.J., Hu, P., Han, M., Ellis, N. and Jasin, M. (2001) Ku DNA end-binding
protein modulates homologous repair of double-strand breaks in
mammalian cells. Genes Dev. 15, 3237–3242.
[132] Wu, D., Topper, L.M. and Wilson, T.E. (2008) Recruitment and dissociation of
nonhomologous end joining proteins at a DNA double-strand break in
Saccharomyces cerevisiae. Genetics 178, 1237–1249.
[133] Huang, J. and Dynan, W.S. (2002) Reconstitution of the mammalian DNA
double-strand break end-joining reaction reveals a requirement for an
Mre11/Rad50/NBS1-containing fraction. Nucleic Acids Res. 30, 667–674.
[134] Di Virgilio, M. and Gautier, J. (2005) Repair of double-strand breaks by
nonhomologous end joining in the absence ofMre11. J. Cell Biol. 171, 765–771.[135] Weterings, E. and Chen, D.J. (2008) The endless tale of non-homologous end-
joining. Cell Res. 18, 114–124.
[136] Meek, K., Gupta, S., Ramsden, D.A. and Lees-Miller, S.P. (2004) The DNA-
dependent protein kinase: the director at the end. Immunol. Rev. 200, 132–
141.
[137] Gu, J. et al. (2010) DNA-PKcs regulates a single-stranded DNA endonuclease
activity of Artemis. DNA Repair (Amst) 9, 429–437.
[138] Yannone, S.M., Khan, I.S., Zhou, R.Z., Zhou, T., Valerie, K. and Povirk, L.F.
(2008) Coordinate 5’ and 3’ endonucleolytic trimming of terminally blocked
blunt DNA double-strand break ends by Artemis nuclease and DNA-
dependent protein kinase. Nucleic Acids Res. 36, 3354–3365.
[139] Zhang, X. and Paull, T.T. (2005) The Mre11/Rad50/Xrs2 complex and non-
homologous end-joining of incompatible ends in S. cerevisiae. DNA Repair
(Amst) 4, 1281–1294.
[140] O’Sullivan, R.J. and Karlseder, J. (2010) Telomeres: protecting chromosomes
against genome instability. Nat. Rev. Mol. Cell Biol. 11, 171–181.
[141] Palm, W. and de Lange, T. (2008) How shelterin protects mammalian
telomeres. Annu. Rev. Genet. 42, 301–334.
[142] Denchi, E.L. (2009) Give me a break: how telomeres suppress the DNA
damage response. DNA Repair (Amst) 8, 1118–1126.
[143] Larrivee, M., LeBel, C. and Wellinger, R.J. (2004) The generation of proper
constitutive G-tails on yeast telomeres is dependent on the MRX complex.
Genes Dev. 18, 1391–1396.
[144] Lydall, D. (2003) Hiding at the ends of yeast chromosomes: telomeres,
nucleases and checkpoint pathways. J. Cell Sci. 116, 4057–4065.
[145] Kironmai, K.M. and Muniyappa, K. (1997) Alteration of telomeric sequences
and senescence caused by mutations in RAD50 of Saccharomyces cerevisiae.
Genes Cells 2, 443–455.
[146] Boulton, S.J. and Jackson, S.P. (1998) Components of the Ku-dependent non-
homologous end-joining pathway are involved in telomeric length
maintenance and telomeric silencing. EMBO J. 17, 1819–1828.
[147] Chamankhah, M. and Xiao, W. (1999) Formation of the yeast Mre11–Rad50–
Xrs2 complex is correlated with DNA repair and telomere maintenance.
Nucleic Acids Res. 27, 2072–2079.
[148] Nugent, C.I., Bosco, G., Ross, L.O., Evans, S.K., Salinger, A.P., Moore, J.K., Haber,
J.E. and Lundblad, V. (1998) Telomere maintenance is dependent on activities
required for end repair of double-strand breaks. Curr. Biol. 8, 657–660.
[149] Takata, H., Tanaka, Y. and Matsuura, A. (2005) Late S phase-speciﬁc
recruitment of Mre11 complex triggers hierarchical assembly of telomere
replication proteins in Saccharomyces cerevisiae. Mol. Cell 17, 573–583.
[150] Diede, S.J. and Gottschling, D.E. (2001) Exonuclease activity is required for
sequence addition and Cdc13p loading at a de novo telomere. Curr. Biol. 11,
1336–1340.
[151] Moreau, S., Ferguson, J.R. and Symington, L.S. (1999) The nuclease activity of
Mre11 is required for meiosis but not for mating type switching, end joining,
or telomere maintenance. Mol. Cell Biol. 19, 556–566.
[152] Tomita, K. et al. (2003) Competition between the Rad50 complex and the Ku
heterodimer reveals a role for Exo1 in processing double-strand breaks but
not telomeres. Mol. Cell Biol. 23, 5186–5197.
[153] Tsukamoto, Y., Taggart, A.K. and Zakian, V.A. (2001) The role of the Mre11–
Rad50–Xrs2 complex in telomerase-mediated lengthening of Saccharomyces
cerevisiae telomeres. Curr. Biol. 11, 1328–1335.
[154] Lombard, D.B. and Guarente, L. (2000) Nijmegen breakage syndrome disease
protein and MRE11 at PML nuclear bodies and meiotic telomeres. Cancer Res.
60, 2331–2334.
[155] Zhu, X.D., Kuster, B., Mann, M., Petrini, J.H. and de Lange, T. (2000) Cell-cycle-
regulated association of RAD50/MRE11/NBS1 with TRF2 and human
telomeres. Nat. Genet. 25, 347–352.
[156] Ranganathan, V. et al. (2001) Rescue of a telomere length defect of Nijmegen
breakage syndrome cells requires NBS and telomerase catalytic subunit.
Curr. Biol. 11, 962–966.
[157] Chai, W., Sfeir, A.J., Hoshiyama, H., Shay, J.W. and Wright, W.E. (2006) The
involvement of the Mre11/Rad50/Nbs1 complex in the generation of G-
overhangs at human telomeres. EMBO Rep. 7, 225–230.
[158] Verdun, R.E., Crabbe, L., Haggblom, C. and Karlseder, J. (2005) Functional
human telomeres are recognized as DNA damage in G2 of the cell cycle. Mol.
Cell 20, 551–561.
[159] Celli, G.B. and de Lange, T. (2005) DNA processing is not required for ATM-
mediated telomere damage response after TRF2 deletion. Nat. Cell Biol. 7,
712–718.
[160] Attwooll, C.L., Akpinar, M. and Petrini, J.H. (2009) The mre11 complex and the
response to dysfunctional telomeres. Mol. Cell Biol. 29, 5540–5551.
[161] Dimitrova, N. and de Lange, T. (2009) Cell cycle-dependent role of MRN at
dysfunctional telomeres: ATM signaling-dependent induction of
nonhomologous end joining (NHEJ) in G1 and resection-mediated
inhibition of NHEJ in G2. Mol. Cell Biol. 29, 5552–5563.
[162] Deng, Y., Guo, X., Ferguson, D.O. and Chang, S. (2009) Multiple roles for
MRE11 at uncapped telomeres. Nature 460, 914–918.
[163] Takai, H., Smogorzewska, A. and de Lange, T. (2003) DNA damage foci at
dysfunctional telomeres. Curr. Biol. 13, 1549–1556.
[164] Karlseder, J., Broccoli, D., Dai, Y., Hardy, S. and de Lange, T. (1999) P53- and
ATM-dependent apoptosis induced by telomeres lacking TRF2. Science 283,
1321–1325.
[165] Karlseder, J., Hoke, K., Mirzoeva, O.K., Bakkenist, C., Kastan, M.B., Petrini, J.H.
and de Lange, T. (2004) The telomeric protein TRF2 binds the ATM kinase and
can inhibit the ATM-dependent DNA damage response. PLoS Biol. 2, E240.
B.J. Lamarche et al. / FEBS Letters 584 (2010) 3682–3695 3695[166] Lilley, C.E., Schwartz, R.A. and Weitzman, M.D. (2007) Using or abusing:
viruses and the cellular DNA damage response. Trends Microbiol. 15, 119–
126.
[167] Stracker, T.H., Carson, C.T. and Weitzman, M.D. (2002) Adenovirus
oncoproteins inactivate the Mre11–Rad50–NBS1 DNA repair complex.
Nature 418, 348–352.
[168] Evans, J.D. and Hearing, P. (2005) Relocalization of the Mre11–Rad50–Nbs1
complex by the adenovirus E4 ORF3 protein is required for viral replication. J.
Virol. 79, 6207–6215.
[169] Mathew, S.S. and Bridge, E. (2007) The cellular Mre11 protein interferes with
adenovirus E4 mutant DNA replication. Virology 365, 346–355.
[170] Mathew, S.S. and Bridge, E. (2008) Nbs1-dependent binding of Mre11 to
adenovirus E4 mutant viral DNA is important for inhibiting DNA replication.
Virology 374, 11–22.
[171] Lakdawala, S.S., Schwartz, R.A., Ferenchak, K., Carson, C.T., McSharry, B.P.,
Wilkinson, G.W. and Weitzman, M.D. (2008) Differential requirements of the
C terminus of Nbs1 in suppressing adenovirus DNA replication and
promoting concatemer formation. J. Virol. 82, 8362–8372.[172] Boyer, J., Rohleder, K. and Ketner, G. (1999) Adenovirus E4 34k and E4 11k
inhibit double strand break repair and are physically associated with the
cellular DNA-dependent protein kinase. Virology 263, 307–312.
[173] Zhao, X., Madden-Fuentes, R.J., Lou, B.X., Pipas, J.M., Gerhardt, J., Rigell, C.J.
and Fanning, E. (2008) Ataxia telangiectasia-mutated damage-signaling
kinase- and proteasome-dependent destruction of Mre11–Rad50–Nbs1
subunits in Simian virus 40-infected primate cells. J. Virol. 82, 5316–5328.
[174] Wu, X., Avni, D., Chiba, T., Yan, F., Zhao, Q., Lin, Y., Heng, H. and Livingston, D.
(2004) SV40 T antigen interacts with Nbs1 to disrupt DNA replication
control. Genes Dev. 18, 1305–1316.
[175] Lilley, C.E., Carson, C.T., Muotri, A.R., Gage, F.H. and Weitzman, M.D. (2005)
DNA repair proteins affect the lifecycle of herpes simplex virus 1. Proc. Natl.
Acad. Sci. USA 102, 5844–5849.
[176] Gregory, D.A. and Bachenheimer, S.L. (2008) Characterization of mre11 loss
following HSV-1 infection. Virology 373, 124–136.
[177] Dupre, A. et al. (2008) A forward chemical genetic screen reveals an inhibitor
of the Mre11–Rad50–Nbs1 complex. Nat. Chem. Biol. 4, 119–125.
